Sign in
Taking peopleNo phase

Leg cycling versus arm cycling exercise for women with diabetes in pregnancy

Compares leg and arm cycling machines in pregnant women with gestational diabetes.

Key facts

Who runs it
Lahore University of Biological and Applied Sciences
Where
Pakistan1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Effects of Leg Ergometer Versus Arm Ergometer on Blood Glucose, Exercise Tolerance, Weight, and Psychological Stress Among Gestational Diabetic Patients
Status
Recruiting
People taking part
108 people, planned
Started
26 May 2026
Planned end
15 Oct 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Leg Ergometer
  • Arm Ergometer
Record updated
18 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant women with diabetes that started during pregnancy (gestational diabetes). It compares leg cycling exercise with arm cycling exercise.

Age
18 to 35 years
Sex
Women only
Disease stage
Gestational diabetes for the first time, diagnosed by hospital or WHO criteria. Pregnancy of 14-28 weeks (second trimester), one baby only. First or later pregnancies can join. Random capillary glucose < 200 mg/dL (11.1 mmol/L) at screening. Blood pressure below 140/90 mmHg. The obstetrician must clear you for moderate aerobic exercise.
Earlier treatment
People who had a Cesarean section before cannot join.
Biomarker or test result
Random capillary glucose < 200 mg/dL (11.1 mmol/L). Systolic BP < 140 mmHg and Diastolic BP < 90 mmHg. Hb not below 9 g/dL.

Main reasons for not taking part

  • Diabetes (Type 1 or Type 2) before the pregnancy
  • Twins, triplets or more babies, or a known major problem in the baby
  • Major pregnancy problems such as placenta previa or severe pre-eclampsia, or ordered bed rest
  • Anemia with Hb < 9 g/dL
  • Heart, muscle or bone problems or other medical reasons that make exercise unsafe

This trial only enrols pregnant participants. The registry sentence this rests on: Gestational age 14-28 weeks (second trimester).

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Female participants aged 18-35 years
  • Gestational age 14-28 weeks (second trimester)
  • Singleton pregnancy (confirmed by obstetric record) only to avoid complications of multiple gestation
  • Include both primigravida and multigravida (i.e., first or subsequent pregnancy)
  • Women with first time GDM in pregnancy
  • Women with clinical diagnosis of gestational diabetes according to hospital/WHO criteria or hospital diagnostic test
  • Blood glucose levels:; Random capillary glucose < 200 mg/dL at screening (to exclude overt diabetes)
  • Blood pressure:; Systolic BP < 140 mmHg and Diastolic BP < 90 mmHg (no confirmed gestational hypertension); If BP ≥140/90 mmHg, confirm with repeat measurement 4 hours apart; exclude if persistent
  • Willingness to participate and provide written informed consent
  • Medically cleared by obstetrician to participate in moderate aerobic exercise

Who cannot take part

  • Previous Cesarean section or medically indicated bed rest
  • Known pre-existing diabetes mellitus (Type 1 or Type 2 prior to pregnancy)
  • Uncontrolled cardiovascular disease, musculoskeletal, or medical contraindications to exercise
  • Psychiatric conditions severe enough to hinder informed consent
  • Any other medical condition that, in the opinion of the obstetrician, makes participation unsafe
  • Anemic women with Hb < 9 g/dL (excluded to prevent exercise intolerance)
  • Known major obstetric complications (e.g., placenta previa, severe pre- eclampsia)
  • Patients having multiple/twin/triplet pregnancies
  • Known major fetal anomaly

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 35 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The current study is a single-blind, parallel-group randomized controlled trial involving 108 participants with diabetes during pregnancy. The trial will compare leg ergometer with arm ergometer. Interventions will be delivered three times per week for eight weeks. The primary outcomes are glucose, exercise tolerance, weight, and psychological stress. Assessments will be conducted at baseline and after eight weeks. The trial will be carried out at Jinnah hospital, Services hospital, Sir Ganga Ram Hospital, Lahore. The hypothesis is that the leg ergometer including aerobic exercise will result in greater reduction in glucose and exercise tolerance, weight and stress management than arm ergometer.

The 2 groups in the trial

  • Leg ErgometerTreatment being tested

    Leg ergometer is used to assess the blood glucose, exercise tolerance, weight, and psychological stress among gestational diabetic patients

  • Arm ErgometerExisting treatment, for comparison

    Arm ergometer is used to compare with leg ergometer to assess the blood glucose, exercise tolerance, weight, psychological stress among gestational diabetic patients

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of Leg Ergometer Versus Arm Ergometer on Blood Glucose, Exercise Tolerance, Weight, and Psychological Stress Among Gestational Diabetic Patients
Plain-language title
Leg cycling versus arm cycling exercise for women with diabetes in pregnancyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Fit questions
Built from NCT07554287, who can take part
Record updated
18 June 2026